ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc., commonly known for its innovative CoolSculpting technology, is a leading player in the medical aesthetics industry. Headquartered in the United States, the company has established a significant presence in major operational regions worldwide, focusing on non-invasive body contouring solutions. Founded in 2005, ZELTIQ has achieved notable milestones, including the FDA clearance of its flagship product, CoolSculpting, which revolutionised fat reduction treatments.
The core offering, CoolSculpting, utilises advanced cryolipolysis technology to target and eliminate stubborn fat cells without surgery, setting it apart in a competitive market. ZELTIQ's commitment to research and development has solidified its position as a trusted name in aesthetic medicine, with a growing portfolio of products designed to enhance patient outcomes and satisfaction.
+14 vs industry average
ZELTIQ Aesthetics, Inc.’s score of 43 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at ZELTIQ Aesthetics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has below-average carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for ZELTIQ Aesthetics, Inc. yet.
ZELTIQ Aesthetics, Inc.'s reported carbon emissions
ZELTIQ Aesthetics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of AbbVie Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation.
ZELTIQ Aesthetics has not outlined any specific reduction targets or initiatives in its own right. However, it is important to note that the climate commitments and reduction strategies may be influenced by AbbVie Inc.'s sustainability efforts. AbbVie has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP).
As ZELTIQ Aesthetics does not provide its own emissions data or reduction targets, stakeholders may need to refer to AbbVie Inc. for comprehensive insights into the climate commitments and performance metrics relevant to ZELTIQ Aesthetics.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
ZELTIQ Aesthetics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for ZELTIQ Aesthetics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from AbbVie Inc.
Carbon Disclosure Project
Inherited from AbbVie Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for ZELTIQ Aesthetics, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project